Connor, Clark & Lunn Investment Management (CC&L)’s Kindred Biosciences, Inc. KIN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-10,351
| Closed | -$71K | – | 1146 |
|
|
2019
Q3 | $71K | Sell |
10,351
-12,777
| -55% | -$87.6K | ﹤0.01% | 928 |
|
|
2019
Q2 | $193K | Sell |
23,128
-14,921
| -39% | -$125K | ﹤0.01% | 906 |
|
|
2019
Q1 | $349K | Sell |
38,049
-20,226
| -35% | -$186K | ﹤0.01% | 726 |
|
|
2018
Q4 | $638K | Sell |
58,275
-2,300
| -4% | -$25.2K | ﹤0.01% | 648 |
|
|
2018
Q3 | $845K | Sell |
60,575
-5,000
| -8% | -$69.7K | ﹤0.01% | 596 |
|
|
2018
Q2 | $698K | Sell |
65,575
-10,200
| -13% | -$109K | ﹤0.01% | 698 |
|
|
2018
Q1 | $655K | Sell |
75,775
-2,600
| -3% | -$22.5K | ﹤0.01% | 532 |
|
|
2017
Q4 | $741K | Sell |
78,375
-2,500
| -3% | -$23.6K | ﹤0.01% | 563 |
|
|
2017
Q3 | $635K | Buy |
80,875
+2,000
| +3% | +$15.7K | ﹤0.01% | 602 |
|
|
2017
Q2 | $678K | Buy |
78,875
+8,250
| +12% | +$70.9K | ﹤0.01% | 553 |
|
|
2017
Q1 | $498K | Buy |
70,625
+4,700
| +7% | +$33.1K | ﹤0.01% | 629 |
|
|
2016
Q4 | $280K | Buy |
65,925
+2,400
| +4% | +$10.2K | ﹤0.01% | 730 |
|
|
2016
Q3 | $316K | Buy |
63,525
+800
| +1% | +$3.98K | ﹤0.01% | 665 |
|
|
2016
Q2 | $222K | Buy |
62,725
+350
| +0.6% | +$1.24K | ﹤0.01% | 729 |
|
|
2016
Q1 | $215K | Sell |
62,375
-5,700
| -8% | -$19.6K | ﹤0.01% | 705 |
|
|
2015
Q4 | $231K | Buy |
68,075
+4,075
| +6% | +$13.8K | ﹤0.01% | 684 |
|
|
2015
Q3 | $333K | Buy |
64,000
+14,300
| +29% | +$74.4K | ﹤0.01% | 585 |
|
|
2015
Q2 | $339K | Buy |
49,700
+1,900
| +4% | +$13K | ﹤0.01% | 474 |
|
|
2015
Q1 | $341K | Buy |
47,800
+12,500
| +35% | +$89.2K | ﹤0.01% | 442 |
|
|
2014
Q4 | $263K | Buy |
+35,300
| New | +$263K | ﹤0.01% | 482 |
|